Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Painreform Ltd (PRFX)

Painreform Ltd (PRFX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Painreform Ltd 65 YIGAL ALON ST. TEL AVIV L3 6744316 ISR

www.painreform.com Employees: 7 P: 972-3717-7051

Description:

PainReform Ltd.is a clinical stage specialty pharmaceutical company. It engages in the development of products for the treatment of pain. The company's product pipeline includes PRF-110, a product based on local anesthetic ropivacaine, which is in clinical stage. PainReform Ltd.is based in Herzeliya, Israel.

Key Statistics

Overview:

Market Capitalization, $K 462
Enterprise Value, $K -7,578
Shares Outstanding, K 145
Annual Sales, $ 0 K
Annual Net Income, $ -9,340 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,310 K
EBIT, $ -5,570 K
EBITDA, $ -9,560 K
60-Month Beta 0.56
% of Insider Shareholders 34.40%
% of Institutional Shareholders 37.28%
Float, K 95
% Float 65.60%
Short Volume Ratio 0.56

Growth:

1-Year Return -94.24%
3-Year Return -99.37%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.40 on 08/15/24
Next Earnings Date 11/20/24
Earnings Per Share ttm -36.84
EPS Growth vs. Prev Qtr 85.29%
EPS Growth vs. Prev Year -12.99%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/21/24

PRFX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -450.64%
Return-on-Assets % -241.33%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.52
Interest Coverage -1.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar